Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Matthias Pinter

Medical University of Vienna

Austria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Austria

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (20)

Michael Weber

Lecturer

Medical University of Vienna

AUSTRIA

View details

Michael Schwarz

Medical University of Vienna

AUSTRIA

View details

Fabian Finkelmeier

University Hospital Frankfurt

GERMANY

View details

Marie‐Luise Berres

Prof. Dr. med

GERMANY

View details

Katrin Böttcher

University of Tübingen

GERMANY

View details

Florian Dr. Reiter

GERMANY

View details

Tom Luedde

GERMANY

View details

Najib Ben Khaled

GERMANY

View details

Alessandro Granito

Docenti di ruolo di IIa fascia

University of Bologna

ITALY

View details

Fabio Piscaglia

Director of Division

University of Bologna

ITALY

View details

Ruxandra-Iulia Milos

Medical University of Vienna

AUSTRIA

View details

Mark Bower

Professor

Chelsea and Westminster Hospital

UNITED KINGDOM

View details

Lorenz Balcar

Medical University of Vienna

AUSTRIA

View details

Malte Benedikt Monin

GERMANY

View details

Maria A. Gonzalez‐Carmona

GERMANY

View details

Enrico N De Toni

Ludwig-Maximilians-Universität München

GERMANY

View details

Giuseppe Cabibbo

University of Palermo

ITALY

View details

Michael Trauner

Professor of Medicine and Chair of Gastroenterology and Hepatology

Medical University of Vienna

AUSTRIA

View details

Matthias Jeschke

University Hospital Essen

GERMANY

View details

Lorenza Rimassa

Head of Hepatopancreatobiliary Oncology Unit

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Pinter

Research Interests

Make your next move.

Explore related searches

Articles (20)

Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement

Changing epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policy

Liver transplantation for primary liver cancers in the era of transplant oncology

Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry

Reversing the global burden of hepatocellular carcinoma

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study

Hepatocellular carcinoma in people living with HIV

Optimizing Imaging Parameters for Assessment of Hepatocellular Carcinoma Using Photon-Counting Detector Computed Tomography—Impact of Reconstruction Kernel and Slice Thickness

Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study

Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis

Reply: Immortal time bias in the management of patients with HCC who achieved CR following immunotherapy-based systemic therapy

Reply: Clarifying the impact of response criteria and locoregional therapy on complete response outcomes in patients with hepatocellular carcinoma following immunotherapy

Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence

Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction

Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease

High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events

The Influence of Sex and Age on Survival in Patients with Hepatocellular Carcinoma

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply

Collaborators (20)

Michael Weber

Michael Schwarz

Fabian Finkelmeier

Marie‐Luise Berres

Katrin Böttcher

Florian Dr. Reiter

Tom Luedde

Najib Ben Khaled

Alessandro Granito

Fabio Piscaglia

Ruxandra-Iulia Milos

Mark Bower

Lorenz Balcar

Malte Benedikt Monin

Maria A. Gonzalez‐Carmona

Enrico N De Toni

Giuseppe Cabibbo

Michael Trauner

Matthias Jeschke

Lorenza Rimassa

Make your next move.